Ranibizumab and bevacizumab for neovascular age-related macular degeneration. DF Martin, MG Maguire, GS Ying, JE Grunwald, SL Fine, GJ Jaffe The New England journal of medicine 364 (20), 1897-1908, 2011 | 2519 | 2011 |
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results DF Martin, MG Maguire, SL Fine, G Ying, GJ Jaffe, JE Grunwald, C Toth, ... Ophthalmology 119 (7), 1388-1398, 2012 | 2034* | 2012 |
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel DA Jabs, JT Rosenbaum, CS Foster, GN Holland, GJ Jaffe, JS Louie, ... American journal of ophthalmology 130 (4), 492-513, 2000 | 1170 | 2000 |
Intravitreal aflibercept for diabetic macular edema JF Korobelnik, DV Do, U Schmidt-Erfurth, DS Boyer, FG Holz, JS Heier, ... Ophthalmology 121 (11), 2247-2254, 2014 | 1008 | 2014 |
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies U Schmidt-Erfurth, PK Kaiser, JF Korobelnik, DM Brown, V Chong, ... Ophthalmology 121 (1), 193-201, 2014 | 935 | 2014 |
HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration PU Dugel, A Koh, Y Ogura, GJ Jaffe, U Schmidt-Erfurth, DM Brown, ... Ophthalmology 127 (1), 72-84, 2020 | 783 | 2020 |
Optical coherence tomography to detect and manage retinal disease and glaucoma GJ Jaffe, J Caprioli American journal of ophthalmology 137 (1), 156-169, 2004 | 672 | 2004 |
Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies DM Brown, U Schmidt-Erfurth, DV Do, FG Holz, DS Boyer, E Midena, ... Ophthalmology 122 (10), 2044-2052, 2015 | 654 | 2015 |
Five-year outcomes with anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration … MG Maguire, DF Martin, G Ying, GJ Jaffe, E Daniel, JE Grunwald, CA Toth, ... Ophthalmology 123 (8), 1751-1761, 2016 | 649 | 2016 |
Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3 SR Sadda, R Guymer, FG Holz, S Schmitz-Valckenberg, CA Curcio, ... Ophthalmology 125 (4), 537-548, 2018 | 612 | 2018 |
Adalimumab in patients with active noninfectious uveitis GJ Jaffe, AD Dick, AP Brézin, QD Nguyen, JE Thorne, P Kestelyn, ... New England Journal of Medicine 375 (10), 932-943, 2016 | 581 | 2016 |
Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group RF Spaide, GJ Jaffe, D Sarraf, KB Freund, SR Sadda, G Staurenghi, ... Ophthalmology 127 (5), 616-636, 2020 | 539 | 2020 |
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four–week results of a multicenter randomized clinical study GJ Jaffe, D Martin, D Callanan, PA Pearson, B Levy, T Comstock, ... Ophthalmology 113 (6), 1020-1027, 2006 | 535 | 2006 |
Ranibizumab and bevacizumab for neovascular age-related macular degeneration CATT Research Group New England Journal of Medicine 364 (20), 1897-1908, 2011 | 526 | 2011 |
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials JE Grunwald, E Daniel, J Huang, G Ying, MG Maguire, CA Toth, GJ Jaffe, ... Ophthalmology 121 (1), 150-161, 2014 | 523 | 2014 |
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised … QD Nguyen, PT Merrill, GJ Jaffe, AD Dick, SK Kurup, J Sheppard, ... The Lancet 388 (10050), 1183-1192, 2016 | 472 | 2016 |
Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies JS Heier, JF Korobelnik, DM Brown, U Schmidt-Erfurth, DV Do, E Midena, ... Ophthalmology 123 (11), 2376-2385, 2016 | 453 | 2016 |
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. S Haskill, G Martin, L Van Le, J Morris, A Peace, CF Bigler, GJ Jaffe, ... Proceedings of the National Academy of Sciences 88 (9), 3681-3685, 1991 | 436 | 1991 |
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration K Zhang, JJ Hopkins, JS Heier, DG Birch, LS Halperin, TA Albini, ... Proceedings of the National Academy of Sciences 108 (15), 6241-6245, 2011 | 355 | 2011 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion CH Park, GJ Jaffe, S Fekrat American journal of ophthalmology 136 (3), 419-425, 2003 | 352 | 2003 |